Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Schleinitz

Showing results (141-150 of 168) with videos related to

Pageof 17
Sort By:
Rheumatology (Oxford, England)|July 23, 2021
Adipose tissue-derived stromal vascular fraction for treating hands of patients with systemic sclerosis: a multicentre randomized trial Autologous AD-SVF versus placebo in systemic sclerosisAurélie Daumas, Jérémy Magalon, Elisabeth Jouve, et al.
Journal of Human Immunity|December 15, 2025
Intronic branchpoint-to-acceptor variants underlying inborn errors of immunityNajiba Alioua, Nathalie Lambert, Mathilde Puel, et al.
Orphanet Journal of Rare Diseases|April 30, 2023
French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromesMatthieu Groh, Julien Rohmer, Nicolas Etienne, et al.
Annals of the Rheumatic Diseases|September 21, 2023
Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective studyBerengere Molina, Roberto Padoan, Maria Letizia Urban, et al.
Medicine|December 27, 2011
IgG4-related systemic disease: features and treatment response in a French cohort: results of a multicenter registryMikael Ebbo, Laurent Daniel, Michel Pavic, et al.
The Journal of Experimental Medicine|December 5, 2025
Autoantibodies neutralizing type I IFNs in patients with fulminant herpes simplex virus hepatitisAdrian Gervais, Astrid Marchal, Soraya Boucherit, et al.
Journal of Clinical Immunology|November 22, 2024
2q33 Deletions Underlying Syndromic and Non-syndromic CTLA4 DeficiencyCharlyne Brakta, Anne-Claude Tabet, Mathilde Puel, et al.
The New England Journal of Medicine|June 3, 2026
Obexelimab for the Treatment of IgG4-Related DiseaseEmanuel Della-Torre, Matthew C Baker, Wen Zhang, et al.
United European Gastroenterology Journal|June 20, 2020
European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendationsJ-Matthias Löhr, Ulrich Beuers, Miroslav Vujasinovic, et al.
Journal of Clinical Immunology|November 28, 2025
IgA and IgM-enriched Immunoglobulins in Primary Immunodeficiencies: a Pilot StudyAurore Collet, Benjamin Coiffard, Emmanuel Ledoult, et al.
Pageof 17

Showing results (141-150 of 168) with videos related to

Sort By:
Pageof 17
Rheumatology (Oxford, England)|July 23, 2021
Adipose tissue-derived stromal vascular fraction for treating hands of patients with systemic sclerosis: a multicentre randomized trial Autologous AD-SVF versus placebo in systemic sclerosisAurélie Daumas, Jérémy Magalon, Elisabeth Jouve, et al.
Journal of Human Immunity|December 15, 2025
Intronic branchpoint-to-acceptor variants underlying inborn errors of immunityNajiba Alioua, Nathalie Lambert, Mathilde Puel, et al.
Orphanet Journal of Rare Diseases|April 30, 2023
French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromesMatthieu Groh, Julien Rohmer, Nicolas Etienne, et al.
Annals of the Rheumatic Diseases|September 21, 2023
Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective studyBerengere Molina, Roberto Padoan, Maria Letizia Urban, et al.
Medicine|December 27, 2011
IgG4-related systemic disease: features and treatment response in a French cohort: results of a multicenter registryMikael Ebbo, Laurent Daniel, Michel Pavic, et al.
The Journal of Experimental Medicine|December 5, 2025
Autoantibodies neutralizing type I IFNs in patients with fulminant herpes simplex virus hepatitisAdrian Gervais, Astrid Marchal, Soraya Boucherit, et al.
Journal of Clinical Immunology|November 22, 2024
2q33 Deletions Underlying Syndromic and Non-syndromic CTLA4 DeficiencyCharlyne Brakta, Anne-Claude Tabet, Mathilde Puel, et al.
The New England Journal of Medicine|June 3, 2026
Obexelimab for the Treatment of IgG4-Related DiseaseEmanuel Della-Torre, Matthew C Baker, Wen Zhang, et al.
United European Gastroenterology Journal|June 20, 2020
European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendationsJ-Matthias Löhr, Ulrich Beuers, Miroslav Vujasinovic, et al.
Journal of Clinical Immunology|November 28, 2025
IgA and IgM-enriched Immunoglobulins in Primary Immunodeficiencies: a Pilot StudyAurore Collet, Benjamin Coiffard, Emmanuel Ledoult, et al.
Pageof 17